Laser Photonics Secures $1.05 Million Order from U.S. Pharmaceutical Manufacturer for High-Speed Tablet Drilling System

ORLANDO, FL / ACCESS Newswire / August 24, 2026 / Laser Photonics Corporation (NASDAQ:LASE) ("Laser Photonics" or the "Company"), a global leader in laser systems for industrial and defense applications, today announced that its subsidiary, CMS Laser, has received a purchase order valued at approximately $1.05 million from a U.S.-based pharmaceutical company for a TD-70 high-speed pharmaceutical tablet drilling system. The order represents a first-time purchase by this customer and marks the Company's entry into a new pharmaceutical manufacturing account, further extending CMS Laser's precision laser drilling franchise within one of the most quality-intensive and highly regulated end markets it serves.

The TD-70 drills the precision orifices that regulate how controlled-release medications are delivered to patients, an application where a fraction of a millimeter can determine therapeutic performance. Two capabilities drove the customer's selection: throughput of up to 70,000 tablets per hour, and a dual-camera vision system that inspects every tablet twice, automatically rejecting any unit outside specification before it moves downstream. Detailed technical specifications for the platform are available on the CMS Laser website.